| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis |
465 |
| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis |
327 |
| Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 |
128 |
| Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016 |
124 |
| Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission |
103 |
| A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study |
90 |
| Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study |
87 |
| Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial |
87 |
| The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017 |
86 |
| Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase open-label, single-arm, dose-escalation trial |
76 |
| Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial |
69 |
| Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium |
68 |
| Human toxocariasis |
64 |
| The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates |
61 |
| Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis |
58 |
| Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study |
58 |
| Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a systematic review and meta-analysis |
57 |
| Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in HIV-infected adults: a prospective cohort study |
54 |
| Institutional trust and misinformation in the response to the 2018-19 Ebola outbreak in North Kivu, DR Congo: a population-based survey |
51 |
| Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study |
50 |
| Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
50 |
| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis |
50 |
| Association between microcephaly, Zika virus infection, and other risk factors in Brazil: final report of a case-control study |
49 |
| Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies |
49 |
| Morbidity and mortality due to shigella and enterotoxigenic Escherichia coli diarrhoea: the Global Burden of Disease Study 1990-2016 |
46 |
| Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study |
45 |
| Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial |
43 |
| Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study |
42 |
| Global and regional molecular epidemiology of HIV- 1990-2015: a systematic review, global survey, and trend analysis |
42 |
| Quantifying drivers of antibiotic resistance in humans: a systematic review |
39 |
| Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase randomised, double-blind, non-inferiority trial |
39 |
| Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial |
39 |
| The global burden of tuberculosis: results from the Global Burden of Disease Study 2015' |
39 |
| Tuberculosis: advances and challenges in development of new diagnostics and biomarkers |
38 |
| Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase non-inferiority trial |
38 |
| Surveillance for control of antimicrobial resistance |
38 |
| Global burden of recurrent vulvovaginal candidiasis: a systematic review |
36 |
| Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011-17: a prospective observational study |
35 |
| Safety and tolerability of a novel, polyclonal human anti-MERS coronavirus antibody produced from transchromosomic cattle: a phase 1 randomised, double-blind, single-dose-escalation study |
34 |
| Molecular surveillance of norovirus, 2005-16: an epidemiological analysis of data collected from the NoroNet network |
32 |
| Prolonged versus short-term intravenous infusion of antipseudomonal beta-lactams for patients with sepsis: a systematic review and meta-analysis of randomised trials |
32 |
| Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine |
31 |
| The effect of global change on mosquito-borne disease |
31 |
| Current gaps in sepsis immunology: new opportunities for translational research |
30 |
| The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017 |
30 |
| Analysis of the clinical antibacterial and antituberculosis pipeline |
28 |
| Antimalarial drug resistance in Africa: the calm before the storm? |
28 |
| Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study |
28 |
| Consumption of oral antibiotic formulations for young children according to the WHO Access, Watch, Reserve (AWaRe) antibiotic groups: an analysis of sales data from 70 middle-income and high-income countries |
28 |
| Prognostic value of interferon-gamma release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study |
28 |
| Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey |
28 |
| Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey |
27 |
| Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study |
27 |
| Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study |
27 |
| Global, regional, and national burden of tuberculosis, 1990-2016: results from the Global Burden of Diseases, Injuries, and Risk Factors 2016 Study |
27 |
| Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem |
27 |
| Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality |
26 |
| Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
26 |
| Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region |
25 |
| Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study |
25 |
| The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study |
24 |
| Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial |
24 |
| Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes |
24 |
| Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study |
24 |
| Multiple-dose versus single-dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicentre, open-label, phase randomised controlled superiority trial |
23 |
| Epidemiology of common resistant bacterial pathogens in the countries of the Arab League |
23 |
| Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis |
23 |
| An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial |
23 |
| Extended-spectrum beta-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study |
23 |
| Experimental infection of human volunteers |
23 |
| Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling |
23 |
| How effective are approaches to migrant screening for infectious diseases in Europe? A systematic review |
22 |
| Risk factors associated with revision for prosthetic joint infection following knee replacement: an observational cohort study from England and Wales |
22 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study |
22 |
| Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak |
22 |
| A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study |
22 |
| Genetics of human susceptibility to active and latent tuberculosis: present knowledge and future perspectives |
21 |
| Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial |
21 |
| Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): a multinational prospective cohort study |
21 |
| Risk factors associated with revision for prosthetic joint infection after hip replacement: a prospective observational cohort study |
21 |
| Implications of insecticide resistance for malaria vector control with long-lasting insecticidal nets: a WHO-coordinated, prospective, international, observational cohort study |
21 |
| Clinical bacteriology in low-resource settings: today's solutions |
21 |
| Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase randomised, clinical trial and post-hoc efficacy analysis |
20 |
| Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial |
20 |
| Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report |
20 |
| Prevalence of abdominal cystic echinococcosis in rural Bulgaria, Romania, and Turkey: a cross-sectional, ultrasound-based, population study from the HERACLES project |
19 |
| Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998-2016: a study of electronic health records |
19 |
| Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study |
19 |
| The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis |
19 |
| Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an international whole-genome sequencing study |
19 |
| Clinical and laboratory predictors of Lassa fever outcome in a dedicated treatment facility in Nigeria: a retrospective, observational cohort study |
19 |
| A multimodal infection control and patient safety intervention to reduce surgical site infections in Africa: a multicentre, before-after, cohort study |
19 |
| Development of vaccines against Zika virus |
18 |
| Long-term all-cause mortality in people treated for tuberculosis: a systematic review and meta-analysis |
18 |
| Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials |
18 |
| Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study |
18 |
| Adjunctive sertraline for HIV-associated cryptococcal meningitis: a randomised, placebo-controlled, double-blind phase 3 trial |
18 |
| The WHO public health approach to HIV treatment and care: looking back and looking ahead |
18 |
| Outbreak investigation of ceftriaxone-resistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad, Pakistan: a matched case-control study |
18 |
| Assessment of ultra-sensitive malaria diagnosis versus standard molecular diagnostics for malaria elimination: an in-depth molecular community cross-sectional study |
17 |
| Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b/4 trial |
17 |
| Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) |
17 |
| Resurgence of scarlet fever in England, 2014-16: a population-based surveillance study |
17 |
| Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study |
17 |
| Effect of infectious disease consultation on mortality and treatment of patients with candida bloodstream infections: a retrospective, cohort study |
17 |
| Prevention of malaria in pregnancy |
17 |
| Antimicrobial resistance following mass azithromycin distribution for trachoma: a systematic review |
17 |
| Potential of marine natural products against drug-resistant bacterial infections |
17 |
| Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial |
16 |
| Antimicrobial resistance among children in sub-Saharan Africa |
16 |
| Models of gonorrhoea transmission from the mouth and saliva |
16 |
| Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysis |
16 |
| Effects of the Australian National Hand Hygiene Initiative after 8 years on infection control practices, health-care worker education, and clinical outcomes: a longitudinal study |
15 |
| Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation |
15 |
| Serocorrelates of protection against infant group B streptococcus disease |
15 |
| Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+1) compared with two primary doses and a booster (2+1) in UK infants: a multicentre, parallel group randomised controlled trial |
15 |
| Peginterferon alfa-2a plus tenofovir disoproxil fumarate for hepatitis D (HIDIT-II): a randomised, placebo controlled, phase 2 trial |
15 |
| Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment |
15 |
| Long-term circulation of Zika virus in Thailand: an observational study |
15 |
| Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report |
15 |
| Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study |
15 |
| Making sense of differences in pneumococcal serotype replacement |
14 |
| The persistence and oscillations of submicroscopic Plasmodium falciparum and Plasmodium vivax infections over time in Vietnam: an open cohort study |
14 |
| Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study |
14 |
| Characterisation of infectious Ebola virus from the ongoing outbreak to guide response activities in the Democratic Republic of the Congo: a phylogenetic and in vitro analysis |
14 |
| Antimalarial activity of single-dose DSM a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study |
14 |
| Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial |
14 |
| Global burden of melioidosis in 2015: a systematic review and data synthesis |
14 |
| Use of ribaxamase (SYN-004), a beta-lactamase, to prevent Clostridium difficile infection in beta-lactam-treated patients: a double-blind, phase 2b, randomised placebo-controlled trial |
14 |
| Tuberculosis susceptibility and protection in children |
14 |
| Prevalence of drug-resistant tuberculosis and imputed burden in South Africa: a national and sub-national cross-sectional survey |
13 |
| Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological study |
13 |
| Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial |
13 |
| Assessment of non-prescription antibiotic dispensing at community pharmacies in China with simulated clients: a mixed cross-sectional and longitudinal study |
13 |
| Sustained transmission of high-level azithromycin-resistant Neisseria gonorrhoeae in England: an observational study |
13 |
| Treatment and secondary prophylaxis with ethanol lock therapy for central line-associated bloodstream infection in paediatric cancer: a randomised, double-blind, controlled trial |
13 |
| Cervical determinants of anal HPV infection and high-grade anal lesions in women: a collaborative pooled analysis |
13 |
| Resurgence of scarlet fever in China: a 13-year population-based surveillance study |
13 |
| Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis |
13 |
| Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial |
13 |
| Schistosomiasis in the first 1000 days |
12 |
| PERISCOPE: road towards effective control of pertussis |
12 |
| Once-daily oral omadacycline versus twice-daily oral linezolid for acute bacterial skin and skin structure infections (OASIS-2): a phase double-blind, multicentre, randomised, controlled, non-inferiority trial |
12 |
| Tenofovir 1% vaginal gel for prevention of HIV-1 infection in women in South Africa (FACTS-001): a phase randomised, double-blind, placebo-controlled trial |
12 |
| Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2-17 years in Asia and Latin America: 18-month interim data from a phase randomised, placebo-controlled study |
12 |
| CAL a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial |
12 |
| Improving the estimation of the global burden of antimicrobial resistant infections |
12 |
| Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial |
12 |
| Safety and immunogenicity of Pfs25H-EPA/Alhydrogel, a transmission-blocking vaccine against Plasmodium falciparum: a randomised, double-blind, comparator-controlled, dose-escalation study in healthy Malian adults |
12 |
| Incidence of paediatric pneumococcal meningitis and emergence of new serotypes: a time-series analysis of a 16-year French national survey |
12 |
| An international outbreak of Salmonella enterica serotype Enteritidis linked to eggs from Poland: a microbiological and epidemiological study |
12 |
| Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase single-centre, double-blind, randomised, controlled study |
12 |
| Clinical utility of existing and second-generation interferon-gamma release assays for diagnostic evaluation of tuberculosis: an observational cohort study |
11 |
| Interventions to improve oral vaccine performance: a systematic review and meta-analysis |
11 |
| Transmission of drug-resistant tuberculosis in HIV-endemic settings |
11 |
| Chlamydia trachomatis and the risk of spontaneous preterm birth, babies who are born small for gestational age, and stillbirth: a population-based cohort study |
11 |
| Immunogenicity and safety of the multicomponent meningococcal B vaccine (4CMenB) in children and adolescents: a systematic review and meta-analysis |
11 |
| Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial |
11 |
| Cost-effectiveness of pre-exposure prophylaxis for HIV prevention in men who have sex with men in the UK: a modelling study and health economic evaluation |
11 |
| Predictors of mortality in patients with yellow fever: an observational cohort study |
11 |
| Comparative efficacy of treatments for Clostridium difficile infection: a systematic review and network meta-analysis |
11 |
| Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial |
11 |
| Active and passive case-finding in tuberculosis-affected households in Peru: a 10-year prospective cohort study |
11 |
| Group B streptococcal disease in UK and Irish infants younger than 90 days, 2014-15: a prospective surveillance study |
11 |
| Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study |
11 |
| Long-term immunity against yellow fever in children vaccinated during infancy: a longitudinal cohort study |
11 |
| The potential effect of improved provision of rabies post-exposure prophylaxis in Gavi-eligible countries: a modelling study |
10 |
| Strategies to improve detection and management of human parechovirus infection in young infants |
10 |
| Internal migration and transmission dynamics of tuberculosis in Shanghai, China: an epidemiological, spatial, genomic analysis |
10 |
| Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions |
10 |
| Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial |
10 |
| Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials |
10 |
| Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study |
10 |
| Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance |
10 |
| Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR Disinfection) |
10 |
| Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis |
10 |
| Infectious causes of microcephaly: epidemiology, pathogenesis, diagnosis, and management |
10 |
| Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study |
9 |
| Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines |
9 |
| The effects of antibiotic cycling and mixing on antibiotic resistance in intensive care units: a cluster-randomised crossover trial |
9 |
| Unexpected outbreaks of arbovirus infections: lessons learned from the Pacific and tropical America |
9 |
| A protracted mumps outbreak in Western Australia despite high vaccine coverage: a population-based surveillance study |
9 |
| The UK's pandemic influenza research portfolio: a model for future research on emerging infections |
9 |
| Prevalence of infection among asymptomatic and paucisymptomatic contact persons exposed to Ebola virus in Guinea: a retrospective, cross-sectional observational study |
9 |
| A governance framework for development and assessment of national action plans on antimicrobial resistance |
9 |
| Tracking spending on malaria by source in 106 countries, 2000-16: an economic modelling study |
9 |
| Long-term incidence of severe malaria following RTS, S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial |
9 |
| Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis |
8 |
| Lassa virus circulating in Liberia: a retrospective genomic characterisation |
8 |
| Epidemic preparedness: why is there a need to accelerate the development of diagnostics? |
8 |
| Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself |
8 |
| Comparative pathogenesis of rabies in bats and carnivores, and implications for spillover to humans |
8 |
| Persistence of Ebola virus after the end of widespread transmission in Liberia: an outbreak report |
8 |
| Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial |
8 |
| Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis |
8 |
| Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial |
8 |
| Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: 10-year follow-up of a phase 3 multicentre, observer-blind, randomised, controlled trial |
7 |
| Targeted point-of-care testing compared with syndromic management of urogenital infections in women (WISH): a cross-sectional screening and diagnostic accuracy study |
7 |
| Association between urinary community-acquired fluoroquinolone-resistant Escherichia coli and neighbourhood antibiotic consumption: a population-based case-control study |
7 |
| Treatment of uncomplicated and severe malaria during pregnancy |
7 |
